Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Cancer
Keeping you updated with all the latest developments, researches, drug trials and treatment protocols for cancer. For detailed information about cancer including cancer types, cancer treatments, cancer drugs, cancer care and also the best cancer hospitals and cancer doctors in Thailand, please visit our other website: www.thailandcancerhelp.com
Source: Thailand Medical News  Nov 27, 2019  4 years ago
University of Western Ontario are conducting a new clinical study that looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. The multi-center trial registry testing the use of a new imaging tracer ie the prostate specific membrane a...
Source: Thailand Medical News  Nov 27, 2019  4 years ago
A new research by Peter MacCallum Cancer Centre has shed new light on why men are more likely than women to get cancer, uncovering a new role for the X chromosome in affecting cancer risk and mortality. While males are known to have a higher risk of developing, and dying from, cancer compared to women even when matched for other known cancer risk factors like age, race, smoking histor...
Source: Thailand Medical News  Nov 26, 2019  4 years ago
Globally, more than 1,180 individuals are diagnosed with pancreatic cancer each day. Within 12 months of diagnosis, 85% will die from it as its one of the most deadly cancers. Despite being lethal, a new research from the University of South Australia could help vastly improve the prognosis for pancreatic cancer patients. Utilizing  a new targeted radioimmunotherapy agent, UniSA Prof...
Source: Thailand Medical News  Nov 25, 2019  4 years ago
Lynparza or Olaparib, is a pharmacological inhibitor of the enzyme PARP (poly ADP Ribose polymerase or PARP) which is required for cancer cell DNA repair. In the presence of certain mutations like BRCA1 and BRCA2, Olaparib kills cancer cells. Olaparib is typically used to treat women suffering from ovarian and breast cancers, has shown promising results when administered to men in whom pro...
Source: Thailand Medical News  Nov 23, 2019  4 years ago
Overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma (HCC) significantly improves with a combination therapy using PD-L1 inhibitor atezolizumab (an immunotherapy drug)  and the VEGF inhibitor bevacizumab,  according to results from a phase 3 study reported at the ESMO Asia 2019 Congress. Dr Ann-Lii Cheng, Director of the National Taiwan...
Source: Thailand Medical News  Nov 22, 2019  4 years ago
Medical researchers from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and oncologists from the Centre Hospitalier Emile Mayrisch (CHEM) are in the process of developing a kit which could facilitate the detection of colorectal cancer at early stage and help clinicians choose the best treatment. Dr. Elisabeth Letellier, principal investig...
Source: Thailand Medical News  Nov 21, 2019  4 years ago
Thailand Cancer News Researchers from the University of Granada (UGR), the Institute of Nanoscience of Aragon (INA), the University of Zaragoza, and the Cancer Research UK Edinburgh Centre at the University of Edinburgh in a collaborative research and study are using “Trojan horses” to combat cancer from within the tumour cells themselves without damaging healthy tissues is the aim of...
Source: Thailand Medical News  Nov 21, 2019  4 years ago
Thailand Cancer News A joint research study by  Cold Spring Harbor Laboratory scientists along with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia. The researchers are the first to demonstrate the anti-cancer effect of blocking the Salt-Inducible Kinase 3 (SIK3) pathway in...
Source: Thailand Medical News  Nov 21, 2019  4 years ago
Thailand Cancer News The University of Barcelona (UB) and Hospital Clínic de Barcelona entered into a collaboration with pharma giant, Boehringer Ingelheim Inc to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer. This public-private collaboration enabled researchers  to identify molecular mechanisms underlying the lack of ...
Source: Thailand Medical News  Nov 21, 2019  4 years ago
Thailand Cancer A recent study by A QIMR Berghofer, a medical research institute in Queensland, Australia has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells. In mid-2018, the long-acting form of the drug Interferon alpha was approved for use in Australia...
Source: Thailand Medical News  Nov 19, 2019  4 years ago
A new study by researchers from the gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti,holder of the Microbiology and Infectious Diseases Chair at the Collège de France,have dem...
Source: Thailand Medical News  Nov 13, 2019  4 years ago
Researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors. Anthrax may soon help more people win the fight against bladder cancer, which the Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000 and is one of the most expensive cancers to treat....
Source: Thailand Medical News  Nov 12, 2019  4 years ago
A new joint study by the University of Leeds and the University of Aberdeen have identified potential environmental risk factors and new targets for treating an aggressive form of breast cancer.The  new data was presented at the Society for Endocrinology annual conference in Brighton. The study suggests that exposure to common chemicals in our everyday environment may increase the risk of dev...
Source: Thailand Medical News  Nov 05, 2019  4 years ago
As a result of a growing incidence rate of colorectal cancer in the US and also globally, the American College of Physicians (ACP) has issued new revised guidelines that has been published in the Annals Of Internal Medicine.   The guidelines states that doctors should screen for colorectal cancer in average-risk adults who do not have symptoms between the ages of 50 and 75. The frequency of...
Source: Thailand Medical News  Nov 03, 2019  4 years ago
A new study led by Rice University bioscientist Dr Natashat Kirienko and postdoctoral researcher Svetlana Panina found that mitocans, anti-cancer drugs that target mitochondria, are particularly adept at killing leukemia cells, especially when combined with a glycolytic inhibitor, while leaving healthy blood cells in the same sample largely unaffected. The published findings, an open ...
Source: Thailand Medical News  Nov 01, 2019  4 years ago
Two new separate studies conducted by researchers at Massachusetts General Hospital and the other by a team from Univeristy Of Texas MD Anderson Cancer Center in Houston support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The first study by Massa...
Source: Thailand Medical News  Oct 30, 2019  4 years ago
A recent study by scientists from Nara Institute of Science and Technology (NAIST) in Japan reports how an experimental drug agent stops cancer cells from growing. 12 years ago, Indonesian scientists initially reported pentagamavumon-1 (PGV-1), an analogue of a molecule found in turmeric and that has been since discovered to have anti-cancer effects. In the new study, tests on cancer cells and ani...
Source: Thailand Medical News  Oct 30, 2019  4 years ago
Tohoku University researchers in Japan are studying using soundwaves to target sites for drug delivery to treat metastatic breast cancer. Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. The researchers have so far tested the treatment on animal models with metastatic breast cancer and have published their finding...
Source: Thailand Medical News  Oct 29, 2019  4 years ago
Medical researchers from the Bellvitge Biomedical Research Institute (IDIBELL) in Spain have discovered the critical involvement of a cell membrane protein in the development and progression of liver cancer. Clathrin, the protein is known for its key role in the process of internalization of molecules from the extracellular space into the cell, called endocytosis. In this process, the cell memb...
Source: Thailand Medical News  Oct 29, 2019  4 years ago
Medical researchers at Stevens Institute of Technology, New Jersey, US have developed a technique using shortwave rays used in cellphones and airport security scanners, that detects skin lesions and determines whether they are cancerous or benign, a technology that could ultimately be incorporated into a handheld device that could rapidly diagnose skin cancer without a scalpel in sight.   C...
Source: Thailand Medical News  Oct 24, 2019  4 years ago
A latest medical study conducted by Mayo Clinic indicates that a high consumption of dairy products, like milk and cheese increases the risk of developing prostate cancer. The findings of the study has also been published in the Journal of the American Osteopathic Association. At the same time the study showed that plant-based diets played a critical role in decreasing the risk of developing ...
Source: Thailand Medical News  Oct 23, 2019  4 years ago
A new study by the US National Cancer Institute (NCI) shows patients with a rare and life-threatening form of gastrointestinal cancer called Biliary Tract Cancer might live longer if they are aspirin users, with the greatest effect seen in those who had not taken the drug before their cancer diagnosis, the results of a database analysis indicate. The new study however only shows corre...
Source: Thailand Medical News  Oct 21, 2019  5 years ago
Researchers from Sloan Kettering Institute are exploring new ways to deal with cancer including using iron. Cells can die in several ways. One such method, discovered only within the past ten years, is ferroptosis literally, death by the mineral iron. This type of cell death requires iron and is linked to a cell’s use of oxygen for metabolism. Ferroptosis is a main cause of ische...
Source: Thailand Medical News  Oct 20, 2019  5 years ago
Typically the standard treatment protocol for the last 8 years for males with enlarged prostate is a type of drug called a 5-alpha reductase inhibitor (5-ARI). These US FDA approved drugs that also used globally, shrink the gland to improve urinary flow, and the approved forms used for treating enlarged prostates come in two varieties: Proscar (finasteride) and Avodart (dutasteride).However, these...
Source: Thailand Medical News  Oct 16, 2019  5 years ago
Medical researchers from Massey University in New Zealand are developing a new drug that could prevent cancer from becoming resistant to treatment. Treatment resistance is a serious obstacle to the successful treatment of cancer patients because it leads to cancer returning and becoming harder to treat. The drugs being developed blocks an enzyme called APOBEC3B in cancer cells that is re...
Source: Thailand Medical News  Oct 12, 2019  5 years ago
A new study by University of Strathclyde has led to a promising blood test that doctors may soon use to accurately detect brain cancer. The patented technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of cancer.     According to the National Cancer Institute, around 0.6% of people will ...
Source: Thailand Medical News  Oct 11, 2019  5 years ago
Medical researchers from across the Netherlands have discovered that using organoids derived from patient tumors can be used to help determine how well a cancer patient will respond to chemotherapy. In their paper published in the journal Science Translational Medicine, the group describes growing organoids from tumor tissue and testing them with chemo drugs. Organoids are organs grown art...
Source: Thailand Medical News  Oct 08, 2019  5 years ago
Largest study ever that expanded over 3 decades and involved 36,000 participants indicates that an antioxidant found in mushrooms, L-ergothioneine lowers the risks of prostate cancer. Medical Researchers From Tohoku University in Sendai, Japan have discovered through a long term study that involved more than 36,000 Japanese men, that eating mushrooms effectively  lowered the risk of prostate ...
Source: Thailand Medical News  Oct 06, 2019  5 years ago
Since an initial study that was published in February 2017 in the Journal of the National Cancer Institute that showed rates of colorectal cancer have increased for every generation born since 1950, newer studies are emerging each year showing the worrisome trend and with headlines like: “If you’re under 30, your risk for colon cancer just doubled.” “Study finds colore...
Source: Thailand Medical News  Oct 05, 2019  5 years ago
When fungus get into the Gut and other digestive tract organs like the pancreas, it indirectly triggers cancer and other ailments.  With pancreatic cancer, colorectal cancer and also inflammatory bowel diseases on the rise, a team of medical researchers from New York University (NYU) School of Medicine decided to pursues studies focusing on the cause of pancreatic cancer an ddiscovered that a...
Source: Thailand Medical News  Sep 30, 2019  5 years ago
Thailand Cancer New highly accurate single blood tests is not only fast and economical but also has a high degree of accuracy plus it can even distinguish the type of cancer, the stage of cancer and the organs or tissues involved unlike conventional diagnostics. Medical researchers at Dana-Farber Cancer Institute, Boston have developed a  new blood test that has shown ability to screen for n...
Source: Thailand Medical News  Sep 20, 2019  5 years ago
Researchers from Louisiana State University, New Orleans School Of Medicine has found that metformin, a commonly prescribed drug for Type 2 Diabetes, is also  effective in treating cancers that lack a protein called Nischarin. Credit:LSU The medical researchers discovered Nischarin, a protein involved in many biological processes that also acts as a tumor suppressor. Much of the team&rsquo...
Source: Thailand Medical News  Sep 18, 2019  5 years ago
Researchers from the National University of Singapore (NUS) has developed a new anti-cancer drug that has less toxic side effects to the kidneys unlike conventional cancer drugs used I chemotherapy or other cancer treatment protocols. The newly developed drug works like a ‘targeted arrow’ that is delivered directly to the mitochondria, the powerhouses of cancer cells. Once the drug rea...
Source: Thailand Medical News  Aug 08, 2019  5 years ago
A new type of liquid biopsy called TARDIS (TARgeted DIgital Sequencing) which is more than a hundred times sensitive than other blood based cancer monitoring tests has been developed jointly by the Mayo Clinic in Arizona and Translational Genomics Research Institute (TGen), for the detection and management of breast cancer. The new blood tests could help avoid thousands of unnecessary surgeries an...
Source:Thailand Medical News  Jul 25, 2019  5 years ago
Melanoma is the most dangerous type of skin cancer. Statistical data show that in 2018, 6.2 million people were diagnosed with it and about 82, 650 people died from it. Australia and New Zealand have the highest rates of melanoma in the world and also high rates are seen in North America and Northern Europe. Melanoma is more common in men than in women , and affects mostly  white communities....
Source: UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER (proceedings from the ESMO World Congress on Gastrointestinal Cancer 2019 ,Barcelona)  Jul 07, 2019  5 years ago
Globally, colorectal cancer is the second leading cause of cancer-related deaths. It is expected to cause about 1.8 million deaths during 2019. BRAF mutations are estimated to occur in up to 15 percent of patients with mCRC, with V600 being the most common BRAF mutation and representing a poor prognosis for these patients. Now Researchers from The University of Texas MD Anderson Cancer Center h...
Source: Thailand Medical News  Jul 05, 2019  5 years ago
Researchers from the University of Surrey and Royal Surrey County Hospital have made a major breakthrough by treating bladder cancer patients with a type of common flu virus.The oncolytic ('cancer-killing') virus coxsackievirus (CVA21),has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer. The results of the study was published in the medical...
Source: Thailand Medical News  Jun 19, 2019  5 years ago
Researchers from Emory University have discovered that the anti-inflammatory drug called ketorolac, given prior to surgery, can promote long-term survival in animal models of cancer metastasis. The so-called "pro-resolution" therapies can also trigger the immune system to eliminate metastatic cells. The research also suggests that flanking chemotherapy with anti-inflammatory drugs can un...
Source: Thailand Medical News  Jun 17, 2019  5 years ago
Researchers from the University Of Virginia Cancer Center have discovered  a link between unhealthy or unbalanced gut microbiome( commensal dysbiosis) and aggressive metastatic breast cancer.   Dr Melanie Rutkowski, from the Department of Microbiology, Immunology and Cancer Biology and also lead author in the study,  found that if the gut microbiome of animal models are altered, t...
Source: Thailand Medical News  Jun 15, 2019  5 years ago
Pancreatic cancer is one of the most lethal forms of cancer due to its resistance to traditional chemotherapy, but what is worrying is that the number of cases on pancreatic cancer is rising exponentially each year. Projections from the American Cancer Society indicates that about 45,000 people in the US alone and about 1.3 million people worldwide might die from this cancer this year alone , surp...
Source: Thailand Medical News  Jun 14, 2019  5 years ago
Scientists from Rutgers University have developed a novel “Virtual Biopsy” device that can rapidly detect a skin lesion’s depth and determine whether it is malignant or not without the need for any surgical intervention. This ability to analyze a skin tumor non-invasively enables less risky and less distressing environments for patients. Photo credit: Rutgers University   ...
Source: Thailand Medical News  Jun 13, 2019  5 years ago
Researchers with multidisciplinary backgrounds from the University of California, Los Angeles have discovered a more effective method of detecting prostate cancer using a combination MRI (magnetic resonance imaging and also traditional ultrasound guided biopsy. Ultrasound Method   Ultrasound guided biopsy weakness is that it sometimes cannot clearly display the location of the tumors wherea...
Source: Thailand Medical News  Jun 08, 2019  5 years ago
PERSEPHONE , A new trial study by the University of Warwick and the University Of Cambridge has shown that shortening the duration of a therapy for breast cancer patients does not increase the risk of their cancer returning.   This trial addresses the issues of concerning reduction in the length of treatments and attendant toxicities and whether this can be achieved without any worsening of...
Source: Thailand Medical News  Jun 03, 2019  5 years ago
Findings of a study presented during the American Society Of Clinical Oncology (ASCO) Annual 2019 Meeting(31st May to 4th  June)  in Chicago by Dana-Farber Cancer Institute showed that  Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC).   Analytical results of the ANZUP-led international r...
Source: Thailand Medical News  Jun 01, 2019  5 years ago
Scientists at Wake Forests School Of Medicine,North Carolina, conducted a therapeutic study of the effects of using non-thermal radio waves on liver cancer cells. The study concluded that the new targeted therapy has proven to be successful in blocking the growth of liver cancer cells anywhere in the body without damaging healthy cells   The research team headed by Boris Pasche, M.D., Ph.D....
Source: Thailand Medical News  May 25, 2019  5 years ago
There are more than 1.1 million new cases of men diagnosed with Prostate Cancer each year while about 310,000 of them die annually due to the disease. (Figures from Globoscan). Here Thailand Medical News brings you in summarized form, developments this week from across the globe with regards to prostate cancer research and developments for easy reading.     Biomaker, PSA contributes to...
Source: Thailand Medical News  May 23, 2019  5 years ago
Despite the advances in both Immunotherapy and  Targeted Medicine protocols for the treatment of cancer, Chemotherapy is still going to be the mainstay for the next decade or so for  most of Asia due to cost factors and also availability. In fact, statistical data shows the figure of chemotherapies would most likely double by 2025 in Asia from current  2019 levels. But what is tr...
Source: Institute of Cancer Research, UK  May 07, 2019  5 years ago
Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival—and which could be used to pick out patients for more intensive treatment. Men with mutations in the retinoblastoma gene in their tumours were more than three times as likely to die and nearly seven times as likely to relapse on standard treatments as those without th...
Source: Karolinska Institutet  May 05, 2019  5 years ago
Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The researchers envision that this discovery may eventually result in a test that contributes to a more personalised treatment of the disease. Prostate cancer is the most common male cancer in Sweden. App...
Source: Proceedings froms ESTRO 2019, Milan  Apr 29, 2019  5 years ago
A single high dose of radiation that can be delivered directly to the tumour within a few minutes is a safe and effective technique for treating men with low risk prostate cancer, according to a study presented at the ESTRO 38 conference. Radiotherapy traditionally involves a series of lower dose treatments that take place over several days or week. The new treatment is called high dose-rate br...
Source: Proceedings froms ESTRO 2019, Milan  Apr 28, 2019  5 years ago
For females with hormone-driven breast cancer, adding radiation to hormone therapy might keep their cancer from coming back for up to a decade, a new study finds. Breast cancer didn't come back in the same breast for 97.5% of women who had radiation therapy plus hormone therapy compared to just over 92% of women who had hormone therapy alone, the researchers said. In addition, over the stu...
Source: Thomas Jefferson University  Apr 26, 2019  5 years ago
A new colorectal cancer vaccine showed positive results in the phase 1 clinical trial to demonstrate that the approach is safe. The patients treated had no signs of serious adverse events and samples of their blood contained markers of immune activation—an early indication that the vaccine could activate immune cells to fight colorectal tumors and metastases. Further tests to determine if th...
Source: Beth Israel Deaconess Medical Center  Apr 21, 2019  5 years ago
About one in seven women in the world will develop breast cancer in her lifetime. The vast majority of these cancers depend on the hormone estrogen to grow. Estrogen-receptor positive (ER+) breast cancer tumors are frequently treated with the drug tamoxifen, which blocks the hormone's effect on the tumor. However, many tumors eventually become resistant to tamoxifen, allowing cancer to recur o...
Source: University Of Otago  Apr 17, 2019  5 years ago
Oral cancer is known for its high mortality rate in developing countries, but an international team of scientists hope its latest discovery will change that. Researchers from the University of Otago, New Zealand, and the Indian Statistical Institute (ISI), Kolkata, have discovered epigenetic markers that are distinctly different in oral cancer tissues compared to the adjacent healthy tissues in...
Source: University of Michigan  Apr 07, 2019  5 years ago
A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial. The shot, a therapeutic vaccine, injects a specific protein that triggers an immune system response to attack high-risk HPV types that cause nearly all cervical cancer precursors, known as cervical intraep...

MOST READ

Jun 10, 2023  10 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19

Interesting Reads

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023  1 year ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  4 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  4 years ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  4 years ago
Source: Myocardial Injury
Jun 09, 2020  4 years ago
Source: COVID-19 News
May 21, 2020  4 years ago